Posted on: Thursday, August 8th 2013
by Heidi Stevenson
English: Genomic structure of Human papillomavirus HPV Español: Estructura genómica del virus del papiloma humano VPH (Photo credit: Wikipedia)
Scientists who have done extensive research on the topics of immunization and autoimmune disorders have produced a new paper concluding that:
“[P]hysicians should remain within the rigorous rules of evidence-based medicine, to adequately assess the risks versus the benefits of HPV vaccination.
In the context of the paper, it’s quite clear that they are saying the evidence does not support a positive risk-benefit ratio for the human papilloma virus (HPV) vaccines, Gardasil and Cervarix.
The paper starts by discussing three cases of young women, studied by the authors, whose development had been quite normal, yet who experienced ovarian failure after receiving HPV vaccinations. They were studied extensively and all other potential causes were ruled out, leaving only the vaccines as the causative agent. They also point out another well-documented case similar to the ones they had investigated.
These are “only” four young women whose lives have been devastated, but the methods of treating girls who are recently post-menarchal is now to give them hormonal drugs, which can mask the symptoms of ovarian failure. The truth is that we do not know how many have been affected this way, and very likely won’t know for years.
These cases are then compared with the newly-described syndrome, autoimmune/inflammatory syndrome induced by adjuvants (ASIA), which can be characterized by the existence of several criteria. All of the girls fit the definition. Following is a copy of the table that displays which of the symptoms each young woman suffered:
Notice that a positive diagnosis for ASIA requires that the individual suffer from at least two major, or one major and two minor, symptoms. All three of these young women suffered from the vaccine-induced ASIA syndrome.
via Scientists Explain Why HPV Vaccines Are Unsafe | GreenMedInfo | Blog.